Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies-Reference-Cited by-同舟云学术

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

Published:2011-03-28 Issue:1 Volume:6 Page:
ISSN:1556-276X
Container-title:Nanoscale Research Letters
language:en
Short-container-title:Nanoscale Res Lett

Author:

Sanna Vanna,Roggio Anna Maria,Posadino Anna Maria,Cossu Annalisa,Marceddu Salvatore,Mariani Alberto,Alzari Valeria,Uzzau Sergio,Pintus Gianfranco,Sechi Mario

Publisher

Springer Science and Business Media LLC

Subject

Condensed Matter Physics,General Materials Science

Link

http://link.springer.com/content/pdf/10.1186/1556-276X-6-260.pdf

Reference23 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009, 59: 225–249. 10.3322/caac.20006

2. Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004, 351: 1513–1520. 10.1056/NEJMoa041318

3. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA, TAX 327 Investigators: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004, 351: 1502–1152. 10.1056/NEJMoa040720

4. Petrylak DP: The treatment of hormone-refractory prostate cancer: docetaxel and beyond. Rev Urol 2006, 8: S48-S55.

5. Lee E, Kim H, Lee IH, Jon S: In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release 2009, 140: 79–85. 10.1016/j.jconrel.2009.08.014

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems;International Journal of Molecular Sciences;2024-08-28

2. Oligoelectrolyte-mediated, pH-triggered release of hydrophobic drugs from non-responsive micelles: Influence of oligo(2-vinyl pyridine)-loading on drug-loading, release and cytotoxicity;International Journal of Pharmaceutics;2024-08

3. Ameliorative delivery of docetaxel and curcumin using PEG decorated lipomers: A cutting-edge in-vitro/ in-vivo appraisal;Journal of Drug Delivery Science and Technology;2024-08

4. Potential applications of antofine and its synthetic derivatives in cancer therapy: structural and molecular insights;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-06

5. PLGA, a Hauler for Anticancer Drugs: Review;Current Cancer Therapy Reviews;2024-02-19